Rhabdoid TumorSymptoms, Doctors, Treatments, Advances & More
Rhabdoid Tumor Overview
Learn About Rhabdoid Tumor
- Rhabdoid tumor
- Atypical teratoid rhabdoid tumor
- BRAIN TUMOR, POSTERIOR FOSSA, OF INFANCY, FAMILIAL
- Malignant rhabdoid tumor
- RHABDOID TUMOR PREDISPOSITION SYNDROME 1
- Rhabdoid sarcoma
- Rhabdoid tumor predisposition syndrome 2
Rockefeller Outpatient Pavilion
Mrinal Gounder is an Oncologist practicing medicine in New York, New York. Dr. Gounder is rated as an Elite provider by MediFind in the treatment of Rhabdoid Tumor. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Desmoid Tumor, Adult Soft Tissue Sarcoma, Epithelioid Sarcoma, Liposarcoma, and Liver Embolization. Dr. Gounder is currently accepting new patients.
Johns Hopkins Children's Center
Eric Raabe is an Oncologist and a Pediatrics provider practicing medicine in Baltimore, Maryland. Dr. Raabe is rated as an Elite provider by MediFind in the treatment of Rhabdoid Tumor. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Rhabdoid Tumor, Brain Tumor, Gliomatosis Cerebri, and Glioma. Dr. Raabe is board certified in American Board Of Pediatrics. Dr. Raabe is currently accepting new patients.
Rogel Cancer Center
Rashmi Chugh is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Chugh is rated as an Elite provider by MediFind in the treatment of Rhabdoid Tumor. She is also highly rated in 32 other conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Epithelioid Sarcoma, Desmoid Tumor, and Ewing Sarcoma. Dr. Chugh is currently accepting new patients.
Summary: This study is a clinical trial to determine the safety of inoculating G207 (an experimental virus therapy) into a recurrent or refractory cerebellar brain tumor. The safety of combining G207 with a single low dose of radiation, designed to enhance virus replication, tumor cell killing, and an anti-tumor immune response, will also be tested. Funding Source- FDA OOPD
Summary: The purpose of this retrospective and prospective project is to understand the molecular and genetic basis of liver cancer of childhood. Understanding the molecular and genetic bases of liver cancers can offer a better classification based on tumor biology, mechanisms and predisposition.
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

